Cardiol Therapeutics Inc. (TSX:CRDL)
1.580
-0.030 (-1.86%)
Oct 29, 2025, 4:00 PM EDT
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of CAD 149.67 million as of October 29, 2025. Its market cap has decreased by -28.23% in one year.
Market Cap
149.67M
Enterprise Value
131.62M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.58
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from 94.32M to 149.67M, an increase of 58.69%. That is a compound annual growth rate of 6.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 152.51M | 1.03% |
| Dec 31, 2024 | 150.97M | 110.34% |
| Dec 29, 2023 | 71.77M | 63.28% |
| Dec 30, 2022 | 43.96M | -69.05% |
| Dec 31, 2021 | 142.02M | 55.49% |
| Dec 31, 2020 | 91.34M | -22.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.09B |
| Green Thumb Industries | 2.42B |
| dentalcorp Holdings | 2.18B |
| Trulieve Cannabis | 2.05B |
| Sienna Senior Living | 1.85B |
| Extendicare | 1.36B |
| Cronos Group | 1.32B |
| WELL Health Technologies | 1.32B |